Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry.
about
Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-AnalysisRisk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana RegistrySafety and Efficacy of Under-dosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? Yes.Cardiac Evaluation and Monitoring of Patients Undergoing Noncardiac Surgery.Perioperative management of patients on direct oral anticoagulants.Preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants.Management of non-vitamin K antagonist oral anticoagulants in the perioperative settingSafety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.Drug persistence with rivaroxaban therapy in atrial fibrillation patients-results from the Dresden non-interventional oral anticoagulation registryManagement of the patient with an acute coronary syndrome using oral anticoagulation.Dental Procedures in Patients with Atrial Fibrillation and New Oral Anticoagulants.Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelinesPerioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral AnticoagulantsWarfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.Management of peri-operative anti-thrombotic therapy.Perioperative anticoagulation and renal disease: an update.The year in cardiology 2014: arrhythmias and device therapy.Periprocedural management of rivaroxaban-treated patients.Using new oral anticoagulants in patients undergoing major orthopedic surgery.2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.Safety of Anticoagulation Interruption in Patients Undergoing Surgery or Invasive Procedures: A Systematic Review and Meta-analyses of Randomized Controlled Trials and Non-randomized Studies.Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.Gastrointestinal endoscopy in patients receiving novel direct oral anticoagulants: results from the prospective Dresden NOAC registry.Management of rivaroxaban in relation to bodyweight and body mass index.Reversal of dabigatran by idarucizumab: when and how?Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).Update on Anticoagulation: What the Interventional Radiologist Needs to Know.Drug Treatment of Venous Thromboembolism in the Elderly.Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?A Bridge to Nowhere? Benefits and Risks for Periprocedural Anticoagulation in Atrial Fibrillation.Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice.Endoscopy in Patients on Antiplatelet Agents and Anticoagulants.Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures.Effects of heparin bridging anticoagulation on perioperative bleeding and thromboembolic risks in patients undergoing abdominal malignancy surgery.
P2860
Q28085676-8AB2F3B0-9602-4AA9-9ECB-5F54978ACB8FQ30000079-D1095050-4413-4A1B-961E-F9586E952BE4Q30490526-18C4B61C-E73F-4760-97FB-6856D979A4A7Q30979197-25283702-B730-43D9-9AFD-1D2B4DABF58BQ33583698-1394C4D4-106B-4513-A92E-B36FBBDFBC63Q33692054-92E36F3D-039B-48B6-BC3F-885E4E465C1DQ33854667-7485AE7E-C61E-4AD3-99D5-9A45894BFFEDQ34207558-C539202A-DE67-42ED-81AB-783B531FD5ECQ34554492-E33031E6-DFBA-442E-98C0-6FB7E8D5051FQ35239819-03787DA2-CBE0-4FC2-A4B4-CC07C3E404CDQ35991815-6FE9204F-621D-41FC-B6D8-E700EAB6A9FAQ36458951-4B463356-9B7A-4709-BFFF-BBA2F28795D2Q36515685-8F68BCA5-ECAA-437F-B15A-BEE30930888DQ36682317-1DB49A8B-BE22-46DF-A8F2-2FC76911BB67Q37062044-8601B544-1B55-46AA-BC82-85899C584B15Q37253651-87A78955-9FBE-4F63-9C8A-B29E62922E41Q38262325-4B68D6A3-59D2-4A2C-891D-CE7EF2D75F7EQ38273789-8CC25B63-C3E3-4780-B200-AA0781C45917Q38285108-753A9C52-F8B6-4E41-9EAE-BC514FEE900CQ38307425-778459EA-13D9-4E60-A646-124D0FA1C7CAQ38358851-88AF584D-9601-40F5-A654-E9AB45859139Q38411840-CDD73780-1CBC-4231-B9E2-1C7B8FD36D2AQ38647787-4E3CE252-7487-480D-8FA0-554DBD5237CAQ38728496-DD7A4E0A-4E2A-485A-8A25-F01474A3472BQ38779161-9A435659-4D83-4642-9AE7-19A6B5E4A23CQ38792641-3163ADA8-076A-4341-B96B-CD1FAD807C4CQ38811133-F83266FF-65FA-405C-9489-4C20E22B0B57Q38831682-11D629D1-7644-4D09-9482-8E1B75555748Q38844635-1AE2E9F4-197A-405C-B026-410DF8D1E810Q38849824-135F36DE-F825-4942-9C5A-940CF369CA4FQ38851927-E83BF67D-73AD-4E96-AE10-B0C293F27711Q38860492-8AEF793C-FBEB-4612-BE16-F5C8F5C64C67Q38895665-3BE94621-52BF-4742-975F-DB3DC99F8DE3Q38939246-DCE5615C-2C68-464E-BCBD-E8B067C9CAD4Q38975409-291AB4CA-B1A3-439E-A394-5ADFCC9869FCQ39028122-AC7B0DCB-5C55-4575-BF9C-A48105463E0CQ39187952-980E03F8-0214-43D2-BB91-6302357AC18BQ39328083-BA294953-827A-486B-B2C9-AE143344EDD2Q39448172-829BCB1E-9580-49C6-A050-FFC0F6A7D1D2Q39749202-AEF41174-88E0-4B5B-8F8C-655C0F58C4B6
P2860
Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Peri-interventional management ...... pective Dresden NOAC registry.
@en
Peri-interventional management ...... pective Dresden NOAC registry.
@nl
type
label
Peri-interventional management ...... pective Dresden NOAC registry.
@en
Peri-interventional management ...... pective Dresden NOAC registry.
@nl
prefLabel
Peri-interventional management ...... pective Dresden NOAC registry.
@en
Peri-interventional management ...... pective Dresden NOAC registry.
@nl
P2093
P2860
P356
P1476
Peri-interventional management ...... pective Dresden NOAC registry.
@en
P2093
Christina Köhler
Christoph Thieme
Eberhard Kuhlisch
Franziska Ebertz
Jan Beyer-Westendorf
Katharina Daschkow
Kati Förster
Norbert Weiss
Sebastian Werth
Thoralf Stange
P2860
P304
P356
10.1093/EURHEARTJ/EHT557
P577
2014-01-06T00:00:00Z